| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $33.7M | — | -20.3% |
| Cost of Revenue | $19.1M | — | -43.2% |
| Gross Profit | $14.6M | — | +68.2% |
| R&D Expense | $9.4M | — | -13.4% |
| SG&A Expense | $6.3M | — | -16.0% |
| Operating Income | -$9.6M | — | +54.2% |
| Interest Expense | $2.0M | — | +123.7% |
| Pre-tax Income | -$11.6M | — | +46.9% |
| Income Tax | $378K | — | -91.7% |
| Net Income | -$12.0M | — | +54.6% |
| EPS (Basic) | -$0.42 | — | +55.8% |
| EPS (Diluted) | -$0.42 | — | +55.8% |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $35.6M | -11.8% | -38.7% |
| Inventory | $37.5M | -10.6% | -32.5% |
| Current Assets | $120.2M | -11.9% | -30.0% |
| Total Assets | $159.3M | -8.3% | -28.7% |
| Current Liabilities | $133.6M | -1.7% | +53.0% |
| Long-term Debt | $67.0M | -1.0% |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.8M | — | +69.2% |
| Capital Expenditures | $217K | — | -87.7% |
| Investing Cash Flow | -$1.7M | — | +45.3% |
| Financing Cash Flow | -$664K | — | -101.7% |
| Free Cash Flow | -$5.0M | — | +71.1% |
| +4.9% |
| Total Liabilities | $172.4M | -2.6% | +3.4% |
| Stockholders' Equity | -$13.1M | -305.3% | -123.1% |